Emerging brain-computer interfaces (BCIs), electroceutical implants, and continuous physiological monitoring systems rely on invasive metallic microelectrodes or classical bio-potential sensors. These technologies suffer from three fatal limitations: (1) biological foreign-body responses, glial scarring, and neuro-inflammatory degradation that destroy long-term signal fidelity; (2) fundamental electrophysiological noise floors (≈ 1–10 µV/√Hz) that obscure sub-cellular synaptic action potentials and picotesla biomagnetic fields; and (3) pervasive data-harvesting vulnerabilities, wherein raw neurological telemetry and somatic signatures are transmitted across unencrypted wireless links, exposing cognitive privacy and biometric identity to commercial artificial intelligence harvesting and unauthorized foundation-model distillation. This monograph establishes the theoretical formulation, physical-layer engineering, and cryptographic governance architecture for Bio-Integrated Quantum Diamond Sensors (BQDS): (1) We model optically detected magnetic resonance (ODMR) in nitrogen-vacancy (NV^-) centers embedded in surface-functionalized nanodiamonds and flexible lithium niobate (LiNbO3) phononic substrates, achieving a magnetic sensitivity floor of η_B ≤ 8.5 pT/√Hz at physiological temperature (T ≈ 310 K); (2) We derive non-Markovian vibronic shielding equations demonstrating that bio-compatible acoustic superlattices filter out destructive thermal phonon modes, extending ground-state electron spin coherence to T_2^* ≥ 1.45 µs and spin-lattice relaxation to T_1 ≥ 4.8 ms; (3) We construct the Somatic Cryptographic Interlock (SCI), which transduces chaotic micro-variations in cardiac intervals and axonal firing sequences directly into true quantum random bitstreams (H_∞ ≥ 0.992 bits/bit), generating on-chip zero-knowledge authentication proofs without disclosing raw physiological waveforms; and (4) We formulate an autonomous bio-hardware circuit breaker that optically decouples wireless transceivers in under 12 ns upon detecting unauthorized interrogation or electromagnetic probing. We prove that this architecture guarantees cognitive privacy under GDPR Article 9 while enforcing director fiduciary obligations under Delaware Caremark corporate governance.
No takes yet. Share an insight, caveat, or question.
Yoko Hasebe (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: